The University of Edinburgh and FUJIFILM Diosynth Biotechnologies UK (FDB) are leading an £8.7 million, five-year research collaboration to develop more cost-effective ways to make modern antibody-based medicines.
This high value reference tool enables the industry to screen for genes associated with desired phenotypes and to help drive innovation in bioproduction.